Patent Assignment
Reel/Frame 014681/0988
Assignment of Assignor's Interest
Recorded: 2003-11-12
Pages: 5
Assignors
BOREA L, PIER ANDREA
Executed: 2003-09-19
BARALDI, PIER GIOVANNI
Executed: 2003-09-19
CHEN, SHIH-FONG
Executed: 2003-11-03
LEUNG, EDWARD
Executed: 2003-09-22
Assignee
KING PHARMACEUTICALS RESEARCH & DEVELOPMENT,INC.
4000 CENTREGREEN WAY, CENTREGREEN TWO, SUITE 300, CARY, NORTH CAROLINA, 27513
Covered Property
(1)
Enhancing treatment of MDR cancer with adenosine A3 antagonists
Application:
10/603,406 →
Publication:
US 2004/0067932
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the 1ST Assignor's Name. Document Previously Recorded on Reel 014681 Frame 0988. Assignor Hereby Confirm the Assignment of the Entire Interest.
Jun 21, 2004
From: BOREA, PIER ANDREA; BARALDI, PIER GIOVANNI; CHEN, SHIH-FONG; LEUNG, EDWARD
To: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
Reel/Frame 015486/0573 →
Security Agreement
Dec 30, 2008
From: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0870 →
Release of Security Interest
May 11, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0022 →